Literature DB >> 19001077

Liver transcriptome profiles associated with strain-specific Ehrlichia chaffeensis-induced hepatitis in SCID mice.

Koshiro Miura1, Yasuko Rikihisa.   

Abstract

Infection of humans with Ehrlichia chaffeensis, the etiologic agent of human monocytic ehrlichiosis, can cause hepatitis of various levels of severity. When the three human isolates of E. chaffeensis, each belonging to a different genogroup, are inoculated into severe combined immunodeficiency mice, the order of severity of clinical signs and bacterial burden detected in the liver is as follows (from greatest to least severity and highest to lowest burden): strain Wakulla, followed by strain Liberty, followed by strain Arkansas. In this article, we used microarray analysis to define transcriptional profiles characteristic of the histopathological features in the mouse liver. Cytokine and chemokine profiles and their receptor profiles were strikingly different among the three strains of E. chaffeensis: gamma interferon, CCL5, CXCL1, CXCL2, CXCL7, CXCL9, interleukin 2 receptor gamma (IL2Rgamma), IL21R, CCR2, and CXCR6 were highly upregulated with strain Arkansas; and tumor necrosis factor (TNF), CCL2, CCL3, CCL5, CCL6, CCL12, CCL20, CXCL2, CXCL7, CXCL9, CXCL13, TNF receptor superfamily 9 (TNFRSF9), TNFRSF13beta, IL1R2, IL2Rgamma, IL20Rbeta, IL21R, CCR1, CCR2, and CXCR4 were highly upregulated with strain Wakulla. With strain Liberty, only CXCL13 was highly upregulated, and IL13Ralpha2 was downregulated. In livers infected with the Arkansas strain, monocytes/macrophages and NK cells were enriched in the granulomas and an increase in NK cell marker mRNAs was detected. Livers infected with the Wakulla strain displayed infiltration of significantly more neutrophils and an increase in neutrophil marker mRNAs. Genes commonly upregulated in liver tissue infected with the three strains are other host innate immune and inflammatory response genes, including those encoding several acute-phase proteins. Genes downregulated commonly are related to host physiologic functions. The results suggest that marked modulation of host cytokine and chemokine profiles by E. chaffeensis strains underlies the distinct host liver disease.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19001077      PMCID: PMC2612275          DOI: 10.1128/IAI.00979-08

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  64 in total

Review 1.  The biology of chemokines and their receptors.

Authors:  D Rossi; A Zlotnik
Journal:  Annu Rev Immunol       Date:  2000       Impact factor: 28.527

2.  IP-10 is critical for effector T cell trafficking and host survival in Toxoplasma gondii infection.

Authors:  I A Khan; J A MacLean; F S Lee; L Casciotti; E DeHaan; J D Schwartzman; A D Luster
Journal:  Immunity       Date:  2000-05       Impact factor: 31.745

Review 3.  Innate immune recognition.

Authors:  Charles A Janeway; Ruslan Medzhitov
Journal:  Annu Rev Immunol       Date:  2001-10-04       Impact factor: 28.527

Review 4.  Alpha(1)-acid glycoprotein: an acute phase protein with inflammatory and immunomodulating properties.

Authors:  Tino Hochepied; Franklin G Berger; Heinz Baumann; Claude Libert
Journal:  Cytokine Growth Factor Rev       Date:  2003-02       Impact factor: 7.638

5.  Analysis of a 1-Mb BAC contig overlapping the mouse Nkrp1 cluster of genes: cloning of three new Nkrp1 members, Nkrp1d, Nkrp1e, and Nkrp1f.

Authors:  B Plougastel; K Matsumoto; C Dubbelde; W M Yokoyama
Journal:  Immunogenetics       Date:  2001-09       Impact factor: 2.846

Review 6.  Hijacking and exploitation of IL-10 by intracellular pathogens.

Authors:  S Redpath; P Ghazal; N R Gascoigne
Journal:  Trends Microbiol       Date:  2001-02       Impact factor: 17.079

7.  RANTES deposition by platelets triggers monocyte arrest on inflamed and atherosclerotic endothelium.

Authors:  P von Hundelshausen; K S Weber; Y Huo; A E Proudfoot; P J Nelson; K Ley; C Weber
Journal:  Circulation       Date:  2001-04-03       Impact factor: 29.690

Review 8.  Lipopolysaccharides in liver injury: molecular mechanisms of Kupffer cell activation.

Authors:  Grace L Su
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2002-08       Impact factor: 4.052

9.  Molecular heterogeneity of Ehrlichia chaffeensis isolates determined by sequence analysis of the 28-kilodalton outer membrane protein genes and other regions of the genome.

Authors:  Chuanmin Cheng; Christopher D Paddock; Roman Reddy Ganta
Journal:  Infect Immun       Date:  2003-01       Impact factor: 3.441

Review 10.  Endothelial activation: intracellular signaling pathways.

Authors:  Jordan S Pober
Journal:  Arthritis Res       Date:  2002-05-09
View more
  14 in total

1.  Ehrlichia chaffeensis induces monocyte inflammatory responses through MyD88, ERK, and NF-κB but not through TRIF, interleukin-1 receptor 1 (IL-1R1)/IL-18R1, or toll-like receptors.

Authors:  Koshiro Miura; Junji Matsuo; M Akhlakur Rahman; Yumi Kumagai; Xin Li; Yasuko Rikihisa
Journal:  Infect Immun       Date:  2011-09-19       Impact factor: 3.441

2.  Penicillin-binding protein of Ehrlichia chaffeensis: cytokine induction through MyD88-dependent pathway.

Authors:  Mohd Akhlakur Rahman; Zhihui Cheng; Junji Matsuo; Yasuko Rikihisa
Journal:  J Infect Dis       Date:  2012-04-26       Impact factor: 5.226

3.  Natural killer cells promote tissue injury and systemic inflammatory responses during fatal Ehrlichia-induced toxic shock-like syndrome.

Authors:  Heather L Stevenson; Mark D Estes; Nagaraja R Thirumalapura; David H Walker; Nahed Ismail
Journal:  Am J Pathol       Date:  2010-07-08       Impact factor: 4.307

4.  Ehrlichia chaffeensis TRP120 binds a G+C-rich motif in host cell DNA and exhibits eukaryotic transcriptional activator function.

Authors:  Bing Zhu; Jeeba A Kuriakose; Tian Luo; Efren Ballesteros; Sharu Gupta; Yuriy Fofanov; Jere W McBride
Journal:  Infect Immun       Date:  2011-08-22       Impact factor: 3.441

5.  Liver Is a Generative Site for the B Cell Response to Ehrlichia muris.

Authors:  Nikita Trivedi; Florian Weisel; Shuchi Smita; Stephen Joachim; Muhamuda Kader; Aditya Radhakrishnan; Chris Clouser; Aaron M Rosenfeld; Maria Chikina; Francois Vigneault; Uri Hershberg; Nahed Ismail; Mark Jay Shlomchik
Journal:  Immunity       Date:  2019-11-12       Impact factor: 31.745

6.  Cyclic dimeric GMP signaling regulates intracellular aggregation, sessility, and growth of Ehrlichia chaffeensis.

Authors:  Yumi Kumagai; Junji Matsuo; Zhihui Cheng; Yoshihiro Hayakawa; Yasuko Rikihisa
Journal:  Infect Immun       Date:  2011-07-25       Impact factor: 3.441

Review 7.  Progress and obstacles in vaccine development for the ehrlichioses.

Authors:  Jere W McBride; David H Walker
Journal:  Expert Rev Vaccines       Date:  2010-09       Impact factor: 5.217

8.  Autoimmune disease triggered by infection with alphaproteobacteria.

Authors:  Javid P Mohammed; Jochen Mattner
Journal:  Expert Rev Clin Immunol       Date:  2009-07-01       Impact factor: 4.473

9.  Review: Protective Immunity and Immunopathology of Ehrlichiosis.

Authors:  Nahed Ismail; Aditya Sharma; Lynn Soong; David H Walker
Journal:  Zoonoses (Burlingt)       Date:  2022-07-05

10.  TLR2 and Nod2 mediate resistance or susceptibility to fatal intracellular Ehrlichia infection in murine models of ehrlichiosis.

Authors:  Partho Chattoraj; Qin Yang; Ankita Khandai; Omar Al-Hendy; Nahed Ismail
Journal:  PLoS One       Date:  2013-03-19       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.